SCI Pharmtech, Inc. (TPE: 4119)

SCI Pharmtech Revenue

SCI Pharmtech had revenue of 419.29M TWD in the quarter ending September 30, 2024, with 62.61% growth. This brings the company's revenue in the last twelve months to 1.41B, up 24.14% year-over-year. In the year 2023, SCI Pharmtech had annual revenue of 1.20B with 33.83% growth.

• Revenue (ttm): 1.41B
• Revenue Growth: +24.14%
• P/S Ratio: 7.10
• Revenue / Employee: 5.91M
• Employees: 239
• Market Cap: 10.13B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	1.20B	304.42M	33.83%
Dec 31, 2022	899.74M	35.52M	4.11%
Dec 31, 2021	864.22M	-1.83B	-67.86%
Dec 31, 2020	2.69B	333.48M	14.16%
Dec 31, 2019	2.36B	415.83M	21.44%